CCL3 augments tumor rejection and enhances CD8+T cell infiltration through NK and CD103+dendritic cell recruitment via IFNγ
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Inflammatory chemokines are critical contributors in attracting relevant immune cells to the tumor microenvironment and driving cellular interactions and molecular signaling cascades that dictate the ultimate outcome of host anti-tumor immune response. Therefore, rational application of chemokines in a spatial-temporal dependent manner may constitute an attractive adjuvant in immunotherapeutic approaches against cancer. Existing data suggest that the macrophage inflammatory protein (MIP)-1 family and related proteins, consisting of CCL3 (MIP-1α), CCL4 (MIP-1β), and CCL5 (RANTES), can be major determinant of immune cellular infiltration in certain tumors through their direct recruitment of antigen presenting cells, including dendritic cells (DCs) to the tumor site. In this study, we examined how CCL3 in a murine colon tumor microenvironment, CT26, enhances antitumor immunity. We identified natural killer (NK) cells as a major lymphocyte subtype that is preferentially recruited to the CCL3-rich tumor site. NK cells contribute to the overall IFNγ content, CD103+ DC accumulation, and augment the production of chemokines CXCL9 and CXCL10 for enhanced T cell recruitment. We further demonstrate that both soluble CCL3 and CCL3-secreting irradiated tumor vaccine can effectively halt the progression of established tumors in a spatial-dependent manner. Our finding implies an important contribution of NK in the CCL3 – CD103+ DC – CXCL9/10 signaling axis in determining tumor immune landscape within the tumor microenvironment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Spranger, S., Bao, R., & Gajewski, T. F. (2015) · Nature · doi:10.1038/nature14404 · Cited by 2,830 · cited 11×
“NK cells can serve as a predominant source of IFNg(16,17) and CD103C DCs have been identified as a major source of CCL4driven CXCL9 and CXCL10 production within TMEs.(4) Therefore, we examined the relative abundance of these important cell populations and their contributions to the differences observed between L3TU an…”
BackgroundResultInfluentialDetermination of subcutaneous tumor size in athymic (nude) mice
Tomayko, M. M., & Reynolds, C. P. (1989) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00300234 · Cited by 1,830 · cited 1×
“Tumor volumes were calculated according to the formula, V D p x D x d(2), where “D” is the larger diameter and “d” is the smaller diameter.(42)”
MethodChemokine expression in melanoma metastases associated with CD8+ T-cell recruitment
Harlin, H., Meng, Y., Peterson, A. C., Zha, Y., Tretiakova, M., Slingluff, C., McKee, M., & Gajewski, T. F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2281 · Cited by 1,121 · cited 11×
“Although T cells constitute another major source of IFNg in the tumor rejection process, our data is further supported by previous studies using IFNg-deficient T cells to demonstrate that NK cells could supply much of the IFNg needed in effective tumor rejection.16 However, NK cells also are dependent on T cells for f…”
BackgroundResultInfluentialSabat, R., Grütz, G., Warszawska, K., Kirsch, S., Witte, E., Wolk, K., & Geginat, J. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.09.002 · Cited by 977
Mikucki, M. E., Fisher, D. T., Matsuzaki, J., Skitzki, J. J., Gaulin, N. B., Muhitch, J. B., Ku, A. W., Frelinger, J. G., Odunsi, K., Gajewski, T. F., et al. (2015) · Nature Communications · doi:10.1038/ncomms8458 · Cited by 512 · cited 1×
“Colon cancer and melanoma have been associated with suppressed expressions of MIP-1 family of proteins that are typically upregulated by their respective normal tissue counterparts under stressed conditions.(21) CCL3, CCL4 and CCL5 share a high degree of homology, and bind to CCR5 (all) and CCR1 (CCL3 and CCL5) on man…”
Background
Cited by
Key chemokines direct migration of immune cells in solid tumors
Kohli, K., Pillarisetty, V. G., & Kim, T. S. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-021-00303-x · Cited by 583
IL-12 Family Cytokines in Cancer and Immunotherapy
Mirlekar, B., & Pylayeva-Gupta, Y. (2021) · Cancers · doi:10.3390/cancers13020167 · Cited by 295
Peña-Romero, A. C., & Orenes-Piñero, E. (2022) · Cancers · doi:10.3390/cancers14071681 · Cited by 257
Seitz, S., Clarke, P., & Tyler, K. L. (2018) · Journal of Virology · doi:10.1128/jvi.00525-18 · Cited by 89
The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer
Wu, M.-F., Lin, C.-A., Yuan, T.-H., Yeh, H.-Y., Su, S.-F., Guo, C.-L., Chang, G.-C., Li, K.-C., Ho, C.-C., & Chen, H.-W. (2021) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-020-02781-8 · Cited by 48
“Since CXCL9 and CCL3 are IFN-γ-related chemokines [30, 31], here we focused E D MPE-Mφ (M1-M2+)”
Background
Metadata
- Authors
- Allen, F., Bobanga, I. D., Rauhe, P., Barkauskas, D., Teich, N., Tong, C., Myers, J., & Huang, A. Y.
- Venue
- OncoImmunology
- Publisher
- Informa UK Limited
- Published
- 2017-11-20
- Volume
- 7
- Issue
- 3
- Pages
- e1393598
- ISSN
- 2162-4011 (ISSN-L)
- 2162-402X
- OpenAlex
- W2765529418
- Cited by
- 148
- References
- 5
- FWCI
- 3.55
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CCL3 augments tumor rejection and enhances CD8+T cell infiltration through NK and CD103+dendritic cell recruitment via IFNγ. https://app.cochat.ai/papers/10.1080/2162402x.2017.1393598
- The paper
- Allen, F., Bobanga, I. D., Rauhe, P., Barkauskas, D., Teich, N., Tong, C., Myers, J., & Huang, A. Y. (2018). CCL3 augments tumor rejection and enhances CD8+T cell infiltration through NK and CD103+dendritic cell recruitment via IFNγ. OncoImmunology. https://doi.org/10.1080/2162402x.2017.1393598
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.